June 24, 2015.
A study of the European Laboratory Information Management System (LIMS) market by Frost & Sullivan reveals that the market earned revenues of $303.5 million in 2014 and estimates it to reach $394.1 million in 2021. The need for genetic and molecular testing data management solutions will generate strong demand for these products, says the report. However, according to analyst Srinivas Sashidhar, for the specialized process of genetic testing, "traditional LIMS will have to undergo modifications to suit the workflow requirements of a genetic laboratory". LIMS must therefore "evolve to have higher data storage capacity, as well as the ability to detect genetic arrangements and access sample records that contain gene database information". All this is achievable adds Frost & Sullivan, but justifying the return on investment after replacing old LIMS "will be a challenge for vendors in western Europe". For more on this report, visit: http://corpcom.frost.com/forms/EU_PR_AZanchi_MADD-52_15Jun15
Can Data and AI Deliver Whole-Person Health?
July 9th 2024Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies.